OGI Organigram Global Inc. - Common Shares

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · organigram.ca

0.9349USD-1.91%Mkt Cap: 134.39M $P/E: 2.27Today

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vap…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap134.39M USD

Enterprise Value225.44M USD

Revenue (TTM)309.18M USD

Gross Profit90.22M USD

Net Income (TTM)-24.76M USD

Revenue/Share2.27 USD

Last Price0.9349 USD

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees1.1K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)2.27

P/E (Forward)39.71

PEG—

EV/EBITDA13.72

EV/Revenue0.73

P/S0.43

P/B0.39

EPS (TTM)0.43

EPS (Forward)0.02

52W Range

0.85306% of range2.240

52W High2.240 USD

52W Low0.8530 USD

Profitability

Gross Margin34.81%

Oper. Margin5.04%

EBITDA Margin5.31%

Profit Margin-9.55%

ROE-7.09%

ROA-4.40%

Growth

Revenue Growth49.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-7.59M USD

CapEx (TTM)17.05M USD

FCF Margin-0.40%

FCF Yield-0.93%

Net Debt19.98M USD

Net Debt/EBITDA1.22

Balance Sheet

Debt/Equity0.03

Current Ratio2.61

Quick Ratio0.94

Book Value/Sh2.42 USD

Cash/Share0.08 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:4

Split DateJul 7, 2023

Analyst Consensus

Rating1.6 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.141.01M

Float97.33M

Insiders31.06%

Institutions6.54%

Short Interest

Short Ratio9.0d

Short % Out.3.38%

Shares Short4.87M

Short (prev mo.)4.83M

Technical

SMA 501.103 (-15.3%)

SMA 2001.285 (-27.2%)

Beta1.91

S&P 52W Chg14.58%

Avg Vol (30d)596.23K

Avg Vol (10d)610.10K

Technical Indicators

RSI (14)31.1

MACD-0.0308

MACD Signal-0.0131

MACD Hist.-0.0177

BB Upper1.210 USD

BB Middle1.085 USD

BB Lower0.9603 USD

BB Width23.04%

ATR (14)0.0511 USD

Vol Ratio (20d)1.31x